Galapagos Reports Positive Phase 2 Trial Data of Crohn’s Disease Drug Filgotinib at ECCO Congress
Crohn's Disease, News
Galapagos recently presented data from the FITZROY Phase 2 clinical trial of filgotinib for Crohn’s disease at the 11th ECCO Congress in Amsterdam. Prof. Séverine Vermeire, lead investigator of the trial, presented ... Read more